Sign in
Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations
Journal article   Open access  Peer reviewed

Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations

Stefan O Ciurea, Abhishek Chilkulwar, Rima M Saliba, Julianne Chen, Gabriela Rondon, Keyur P Patel, Haitham Khogeer, Abdul R Shah, Brion V Randolph, Jorge M Ramos Perez, …
Blood, Vol.131(26), pp.2989-2992
28/06/2018
PMID: 29769261

Abstract

Adolescent Adult Aged Female Hematopoietic Stem Cell Transplantation Humans Leukemia, Myeloid, Acute - diagnosis Leukemia, Myeloid, Acute - genetics Leukemia, Myeloid, Acute - therapy Male Middle Aged Mutation Myelodysplastic Syndromes - diagnosis Myelodysplastic Syndromes - genetics Myelodysplastic Syndromes - therapy Prognosis Survival Analysis Transplantation, Homologous Treatment Outcome Tumor Suppressor Protein p53 - genetics Young Adult
url
https://doi.org/10.1182/blood-2018-02-832360View
Published (Version of record) Open

Metrics

1 Record Views

Details